For decades, multiple sclerosis (MS) research has focused largely on the inflammatory lesions visible on MRI scans. Yet new ...

Sanofi SNY announced that the FDA has extended the target action date for its new drug application (NDA) for tolebrutinib by three months. The NDA is seeking approval of tolebrutinib, an oral and ...

Compared with other measures of hypertension, the American Heart Association’s stage II hypertension category had the strongest association with disability worsening in patients with multiple ...

People with multiple sclerosis appear to have higher rates of thyroid problems than the general population. The link isn’t clear, but shared pathways and MS medication side effects may play a role. MS ...

Sleep disorders are highly prevalent among individuals with multiple sclerosis (MS), affecting nearly half of the patient population, according to study results presented at the European Committee for ...

A combination of metformin, a common diabetes drug, and clemastine, an antihistamine, can help repair myelin—the protective ...

Following a competitive selection process, Ashlyn Anderson was chosen as the recipient of the inaugural Tanner MS Scholar Award. Ashlyn is a 4 th year PhD student at the University of Alabama at ...

The largest study of its kind has found menopause is not associated with an increased risk of disability in women with ...